Medtronic Cardiac Rhythm and Heart Failure
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medtronic Cardiac Rhythm and Heart Failure sits in the top decile of US sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count).
Medtronic Cardiac Rhythm and Heart Failure: 115 sponsored US clinical trials, 2 recruiting.
Medtronic Cardiac Rhythm and Heart Failure sponsors 115 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 100 completed. 6 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 10 trials.
Top-decile sponsor footprint
Medtronic Cardiac Rhythm and Heart Failure ranks in the top decile of sponsors by registered trial count (#223 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
100 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
115 total, page 1 of 3
ELEVATE-HFpEF Clinical Study
NCT06678841
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
NCT05839730
Cardiac Implantable Electronic Device (CIED) Research Study
NCT05061862
Destination Therapy Post Approval Study
NCT03681210
Characterizing Outcomes and Real-World Experience of Cardiac Physiologic Pacing (The CORE-CPP Study)
NCT06606288
DelIVery for Pulmonary Arterial Hypertension (PAH) & Continued Support Study
NCT01321073
Crome/Cobalt Respiration Study
NCT06089694
QT Changes as Detected From LINQ ECG During Antiarrhythmic Loading (LINQ QT)
NCT05488470
TYRX™ Pocket Health Study
NCT05356546
Conduction System Pacing Optimized Therapy
NCT04905290
Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
NCT04863664
DEFINE AFib (Atrial Fibrillation)
NCT04926857
Reveal LINQ Respiration Clinical Study
NCT04506684
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
NCT04452149
Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD)
NCT04169529
Accelerometer Sensing for Micra AV Study
NCT04245345
Extravascular ICD Pivotal Study
NCT04060680
SelectSecure 3830 Lead Imaging
NCT03941275
Micra Atrial TRacking Using A Ventricular AccELerometer 2
NCT03752151
Apogee, A HeartWare HVAD Destination Product Surveillance Registry (PSR) Platform
NCT03697980
ECG Belt for CRT Response
NCT03504020
Relationship Between LINQ™ Subcutaneous Impedance and Right-sided Hemodynamic Measurements
NCT03608826
BlueSync Field Evaluation
NCT03518658
Tachy Prediction Download Study
NCT03402126
Imaging Study of Lead Implant for His Bundle Pacing
NCT03294317
REmodeling the Left Ventricle With Atrial Modulated Pacing
NCT03210402
Micra Atrial Tracking Using a Ventricular Accelerometer Study
NCT03157297
Attain Stability™ Quad Clinical Study
NCT03099655
Magnetic Resonance Imaging of Human Biometrics
NCT02942667
Pressure Variability Study
NCT02943941
Reveal LINQ™ Heart Failure
NCT02758301
Acute Study to Collect Electrical Signals From the Heart Using a Special Lead
NCT02772380
Integrated Diagnostics Driven Diuretic and Chronic Medication Management for Heart Failure
NCT02698241
Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin
NCT02700945
SEEQ™ Performance Study
NCT02484898
Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States
NCT02395536
World-wide Randomized Antibiotic Envelope Infection Prevention Trial
NCT02277990
HW006 LATERAL Thoracotomy
NCT02268942
Cardiac Resynchronization Therapy Efficacy Enhancements
NCT02222818
AdaptResponse Clinical Trial
NCT02205359
Reveal LINQ Registry
NCT02746471
Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access
NCT02117414
Feasibility Study of Remote Support for Implantable Pulse Generator (IPG)/Implantable Cardioverter Defibrillator (ICD) Implant
NCT01809652
Micra Transcatheter Pacing Study
NCT02004873
A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL)
NCT01966458
Sensor Optimization of Cardiac Resynchronization Therapy Response
NCT01832493
Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials
NCT01832610
Attain Performa(TM) Quadripolar Lead Study
NCT01751022
MIRACLE EF Clinical Study
NCT01735916
REVEAL AF: Incidence of AF in High Risk Patients
NCT01727297
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Medtronic Cardiac Rhythm and Heart Failure pipeline
2 recruiting of 115 indexed (2% open); 100 completed (87%).
Phase mix: 6 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Heart Failure (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medtronic Cardiac Rhythm and Heart Failure: open-pipeline peers nationwide
Peers matched on 115 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Medtronic Cardiac Rhythm and Heart Failure sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 115 trials (± recruiting share)
- Medstar Health Research Institute · 115 trials · 20% recruiting
- Zimmer Biomet · 115 trials · 10% recruiting
- Rockefeller University · 117 trials · 4% recruiting
- State University of New York - Upstate Medical University · 113 trials · 7% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Eisai · 2% recruiting · 287 trials
- Bausch & Lomb Incorporated · 2% recruiting · 174 trials
- Lexicon Pharmaceuticals · 2% recruiting · 56 trials
- Alcon Research · 2% recruiting · 275 trials
Related
What to do with this Medtronic Cardiac Rhythm and Heart Failure page
115 registered trials is a research-attention snapshot, not an endorsement of Medtronic Cardiac Rhythm and Heart Failure or any single study.
- 2 of Medtronic Cardiac Rhythm and Heart Failure's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Medtronic Cardiac Rhythm and Heart Failure studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medtronic Cardiac Rhythm and Heart Failure pipeline card: 115 registered trials from official public datasets.Report a data error.